Skip to content
Journal article

Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products.

Bae H, Zhao L, Kanim L, Wong P, Delamarter R, Dawson E ...see all

Spine, vol. 31, issue 12 (2006) pp. 1299-306; discussion 1307-8

  • 48

    Readers

    Mendeley users who have this article in their library.
  • 82

    Citations

    Citations of this article.
  • N/A

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Enzyme-linked immunosorbent assay was used to detect bone morphogenetic proteins (BMPs) 2, 4, and 7 in 9 commercially available ("off the shelf") demineralized bone matrix (DBM) product formulations using 3 different manufacturer's production lots of each DBM formulation.

Author-supplied keywords

  • Biological Agents
  • Biological Agents: chemistry
  • Bone Demineralization Technique
  • Bone Matrix
  • Bone Matrix: chemistry
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins
  • Bone Morphogenetic Proteins: analysis
  • Enzyme-Linked Immunosorbent Assay
  • Growth Differentiation Factor 2
  • Growth Differentiation Factors
  • Humans
  • Osmolar Concentration
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta: analysis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Hyun W Bae

  • Li Zhao

  • Linda E a Kanim

  • Pamela Wong

  • Rick B Delamarter

  • Edgar G Dawson

Cite this document

Choose a citation style from the tabs below